Resmed Inc. buy Needham & Company LLC
Start price
25.01.24
/
50%
€173.80
Target price
25.01.25
€197.59
Performance (%)
36.54%
End price
26.01.25
€237.30
Summary
This prediction ended on 26.01.25 with a price of €237.30. The BUY prediction by Needham___Company_LL for Resmed Inc. saw massive gains of 36.54%. Dividends of €1.87 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.219% | 0.219% | -23.679% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $180.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten